Russell Investments Group
STRO icon

Russell Investments Group’s Sutro Biopharma STRO Stock Holding History

Russell Investments Group’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-926
Closed -$6.02K – 3950
2025
Q1 		$6.02K Sell
926
-9,019
-91% -$142K ﹤0.01% 3316
2024
Q4 		$183K Sell
9,945
-5,177
-34% -$158K ﹤0.01% 2560
2024
Q3 		$523K Buy
15,122
+2,299
+18% +$90.1K ﹤0.01% 2263
2024
Q2 		$376K Buy
12,823
+1,627
+15% +$64.3K ﹤0.01% 2302
2024
Q1 		$633K Buy
11,196
+7,374
+193% +$326K ﹤0.01% 2138
2023
Q4 		$164K Sell
3,822
-7,038
-65% -$223K ﹤0.01% 2470
2023
Q3 		$377K Sell
10,860
-2,820
-21% -$123K ﹤0.01% 2323
2023
Q2 		$636K Sell
13,680
-303
-2% -$15.1K ﹤0.01% 2141
2023
Q1 		$646K Buy
13,983
+3,087
+28% +$196K ﹤0.01% 2163
2022
Q4 		$880K Sell
10,896
-30
-0.3% -$2.08K ﹤0.01% 2039
2022
Q3 		$604K Sell
10,926
-2,120
-16% -$125K ﹤0.01% 2166
2022
Q2 		$678K Buy
13,046
+8,028
+160% +$448K ﹤0.01% 2133
2022
Q1 		$410K Buy
5,018
+3,281
+189% +$312K ﹤0.01% 2285
2021
Q4 		$258K Hold
1,737
– – ﹤0.01% 2651
2021
Q3 		$328K Hold
1,737
– – ﹤0.01% 2620
2021
Q2 		$322K Sell
1,737
-3,816
-69% -$747K ﹤0.01% 2754
2021
Q1 		$1.26M Buy
5,553
+430
+8% +$102K ﹤0.01% 2139
2020
Q4 		$1.11M Buy
5,123
+2,334
+84% +$386K ﹤0.01% 2073
2020
Q3 		$278K Buy
2,789
+1,696
+155% +$160K ﹤0.01% 2641
2020
Q2 		$84K Sell
1,093
-29
-3% -$2.78K ﹤0.01% 2919
2020
Q1 		$113K Buy
1,122
+36
+3% +$3.78K ﹤0.01% 2698
2019
Q4 		$118K Buy
+1,086
New +$112K ﹤0.01% 2846

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Russell Investments Group's STRO Position: Q2 2025 in Review

Russell Investments Group sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 926 shares — an estimated $6.02K sold.

Russell Investments Group first reported a position in STRO in Q4 2019 and held it in 22 quarters. The position peaked at $1.26M in Q1 2021. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • Russell Investments Group reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • Russell Investments Group sold 926 Sutro Biopharma shares in Q2 2025, an estimated $6.02K.
  • Russell Investments Group first reported a position in Sutro Biopharma in Q4 2019 and held it in 22 quarters.
  • Russell Investments Group's Sutro Biopharma position peaked at $1.26M in Q1 2021.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on Russell Investments Group's 13F filing for Q2 2025, filed 13 Aug 2025.